Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries's Climate Target Data Preview
As of 2024, Sun Pharmaceutical Industries has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 absolute reduction target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Sun Pharmaceutical Industries ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Sun Pharmaceutical Industries's Greenhouse Gas Emissions Pathways
As of 2024, Sun Pharmaceutical Industries has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.
Does Sun Pharmaceutical Industries have a target to reduce the emissions from its operations?
As of 2024, Sun Pharmaceutical Industries has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.
Sun Pharmaceutical Industries's most ambitious operational target is to reduce these emissions by 35% by 2030, compared to a baseline of 446,501.599 Metric Tonnes of CO2 equivalent (mtCO2e) in 2020.
As of 2024, Sun Pharmaceutical Industries is ahead of schedule on its operational emissions reduction target, having achieved 62.43% of the planned reduction.